AOD- 9604 (5mg)

AOD-9604 (Advanced Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH176-191). It has been studied for its lipolytic properties without triggering IGF-1 elevation or the glycemic and anabolic effects associated with full-length growth hormone. This selectivity makes it a focused research tool for studying fat metabolism independently of GH receptor activation. This 5mg presentation is suited for shorter-cycle or introductory research protocols.

Mechanism of Action

•        Studied for mimicking the lipolytic activity of the C-terminal region of human growth hormone, stimulating fat breakdown in adipocyte research models.

•        Research indicates activation of beta-3 adrenergic receptors in fat cells, influencing thermogenesis and energy expenditure.

•        Does not bind to GH receptors or stimulate IGF-1 production, avoiding growth-promoting side effects observed with full-length hGH in research models.

•        Investigated for simultaneous inhibition of lipogenesis and promotion of fat mobilization in adipose biology studies.

Research Areas

•        Targeted fat metabolism research, particularly visceral and subcutaneous adipose biology.

•        Body recomposition research examining fat reduction without anabolic hormone disruption.

•        Short-cycle combination protocols studied alongside GH secretagogues in fat loss biology models.

•        Weight management research in contexts where full GH biology is not the primary research variable.

Presentation and Storage

Supplied as a lyophilized powder in a sealed vial containing 5mg of AOD-9604. Reconstitute with bacteriostatic water for laboratory use. Store at -20C.